Pingora Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Sell
1,600
-100
-6% -$101K 0.87% 28
2025
Q4
$1.83M Hold
1,700
1.12% 18
2025
Q3
$1.3M Buy
1,700
+100
+6% +$74.4K 0.86% 26
2025
Q2
$1.25M Sell
1,600
-300
-16% -$233K 0.93% 26
2025
Q1
$1.57M Hold
1,900
1.16% 19
2024
Q4
$1.47M Hold
1,900
0.96% 21
2024
Q3
$1.68M Hold
1,900
1.19% 16
2024
Q2
$1.72M Hold
1,900
1.22% 14
2024
Q1
$1.48M Hold
1,900
1.08% 20
2023
Q4
$1.11M Buy
+1,900
New +$1.11M 0.98% 24

Other funds holding LLY

Pingora Partners's LLY Position: Q1 2026 in Review

Pingora Partners reduced its Eli Lilly (LLY) stake by 5.9% in Q1 2026, selling an estimated $101K and leaving 1,600 shares worth $1.47M. The position accounts for 0.87% of the portfolio, ranked #28.

Pingora Partners first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.83M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pingora Partners held 1,600 shares of Eli Lilly worth $1.47M as of Q1 2026.
  • Pingora Partners sold 100 Eli Lilly shares in Q1 2026, an estimated $101K.
  • Eli Lilly made up 0.87% of Pingora Partners's portfolio in Q1 2026, its #28 holding.
  • Pingora Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Pingora Partners's Eli Lilly position peaked at $1.83M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.